Chad Conner has a diverse work experience in the pharmaceutical and cannabis industries. Chad is currently the President of Nova Aurora, a company that creates high-quality ingredients from waste generated by the hemp and psilocybin industries. Prior to that, they served as the Executive VP of Operations and Finance at TradeHelp™, a SaaS system that facilitates trading of physical commodities and trade services. Chad was also the Chief Executive Officer of Mycrodose Therapeutics, where they focused on developing advanced drug delivery systems for mental health and cancer-related indications.
Additionally, Chad has held the position of President at Kelai Pharmaceutical, a company that specializes in creating innovative therapies for addiction and mental health disorders using natural molecules and advanced drug delivery systems. Chad was also the Founder and CEO of Pure Ratios, a CBD hemp company that developed transdermal technology for efficient cannabinoid delivery.
Earlier in their career, Chad served as a Professor and Clinical Supervisor at the Pacific College of Health and Science. Chad also co-founded and served as the Vice President of AccuCanna/Harborside Dispensary, a legal dispensary and health center in California.
Chad has held executive positions at various pharmaceutical companies as well. Chad was the Vice President of International Bioceutical Company LLC and Pavana Pharmaceuticals.
Before their career in the pharmaceutical industry, Chad was the CEO of Institut Wu Wei.
Overall, Chad Conner has significant experience in leadership roles within the pharmaceutical and cannabis industries, with a focus on developing innovative drug delivery systems and creating high-quality products.
Chad Conner completed their education in the field of Traditional Chinese Medicine and Chinese Herbology. Chad attended the Pacific College of Health and Science from 1996 to 1999, earning a Master of Science (MS) degree in this field. Additionally, they obtained a Master Science in Traditional Chinese Medicine certification from the California acupuncture board in November 1998.
Sign up to view 1 direct report
Get started